Skip to content
OccuflowBIO
01legal

Terms of Use

Last updated: August 2026. These terms govern your use of the OccuFlow Bio website.

Acceptance of terms

By accessing this website, you agree to these Terms of Use. If you do not agree, please do not use the website.

Investigational status of OF-01

OF-01 is an investigational new drug candidate. It has not been approved by the U.S. Food and Drug Administration or any other regulatory authority and has not been demonstrated to be safe or effective for any use. All data described on this website are preclinical.

No medical advice

Information provided on this website is for scientific, corporate, and qualified-investor purposes only. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Do not use this website to make medical decisions.

Intellectual property

All content on this website, including text, graphics, and logos, is owned by or licensed to OccuFlow Bio, Inc. and is protected by intellectual property laws. You may not copy, reproduce, or distribute content without prior written permission.

Permitted use

You may use this website for personal, informational, non-commercial purposes. You may not use it to solicit, to send unsolicited communications, or to disrupt its operation.

Third-party links

This website may contain links to third-party websites. We are not responsible for the content or practices of those sites and do not endorse them.

Disclaimer of warranties

This website and its content are provided on an as-is and as-available basis. To the fullest extent permitted by law, we disclaim all warranties, express or implied, regarding accuracy, availability, or fitness for a particular purpose.

Limitation of liability

To the fullest extent permitted by law, OccuFlow Bio, Inc. and its affiliates are not liable for any direct, indirect, incidental, or consequential damages arising from your use of, or inability to use, this website.

Changes to these terms

We may update these Terms of Use from time to time. The most recent revision date appears at the top of this page. Continued use of the website after changes indicates acceptance of the updated terms.

Governing law

These terms are governed by the laws of the State of California, without regard to its conflict-of-law principles.

Contact

Questions about these terms can be directed to gzode@hs.uci.edu or mike@octaneoc.org.

OccuflowBIO

A preclinical-stage ophthalmic biotechnology company developing OF-01 to restore the eye's natural drainage architecture in glaucoma.

contact
  • gzode@hs.uci.edu
  • mike@octaneoc.org
  • 505(b)(2) regulatory pathway
investigational product disclaimer

OF-01 is an investigational new drug candidate. It has not been approved by the U.S. Food and Drug Administration or any other regulatory authority and has not been demonstrated to be safe or effective for any use. All data described on this website are preclinical. Information provided is for scientific, corporate, and qualified-investor purposes only and is not medical advice.

important disclosures

Preclinical Data: Results described are from in vitro, ex vivo human donor tissue, and animal models, some unpublished. Preclinical findings do not reliably predict results in humans.

Forward-Looking Statements: Statements on development plans, regulatory pathway, timelines, and potential outcomes are forward-looking and subject to substantial uncertainty.

No Offer of Securities: This website is not an offer to sell or a solicitation to buy any security.

No Third-Party Endorsement: Universities and institutions named (including UC Irvine) are identified for background only and do not endorse OccuFlow Bio or OF-01.

© 2026 OccuFlow Bio. All rights reserved.
PRECLINICAL · OF-01 · OPHTHALMOLOGY

Research conducted at UC Irvine (no endorsement implied). OF-01 is an investigational product. Safety and efficacy have not been established.